NDC 49702-207
LEXIVA
Fosamprenavir Calcium
LEXIVA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Fosamprenavir Calcium.
| Product ID | 49702-207_05c0714d-c373-4321-89ac-0acb18394db1 |
| NDC | 49702-207 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LEXIVA |
| Generic Name | Fosamprenavir Calcium |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-10-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021548 |
| Labeler Name | ViiV Healthcare Company |
| Substance Name | FOSAMPRENAVIR CALCIUM |
| Active Ingredient Strength | 700 mg/1 |
| Pharm Classes | Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inducers [MoA], Protease Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 49702-207-18
60 TABLET, FILM COATED in 1 BOTTLE (49702-207-18)
| Marketing Start Date | 2010-10-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 49702-207-18 [49702020718]
LEXIVA TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA021548 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-10-04 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| FOSAMPRENAVIR CALCIUM | 700 mg/1 |
OpenFDA Data
| SPL SET ID: | 24feb9be-32a6-45fd-a896-f3e202edd8a9 |
| Manufacturer | |
| UNII | |
| UPC Code |
Pharmacological Class
- Protease Inhibitor [EPC]
- Cytochrome P450 3A4 Inhibitors [MoA]
- Cytochrome P450 3A4 Inducers [MoA]
- P-Glycoprotein Inducers [MoA]
- HIV Protease Inhibitors [MoA]
Medicade Reported Pricing
49702020718 LEXIVA 700 MG TABLET
Pricing Unit: EA | Drug Type:
NDC Crossover Matching brand name "LEXIVA" or generic name "Fosamprenavir Calcium"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49702-207 | LEXIVA | fosamprenavir calcium |
| 49702-208 | LEXIVA | fosamprenavir calcium |
| 53808-0281 | LEXIVA | fosamprenavir calcium |
| 53808-1010 | LEXIVA | fosamprenavir calcium |
| 0378-3520 | Fosamprenavir Calcium | fosamprenavir calcium |
| 63304-583 | Fosamprenavir Calcium | Fosamprenavir Calcium |
Trademark Results [LEXIVA]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LEXIVA 78312751 2928773 Live/Registered |
VIIV HEALTHCARE COMPANY 2003-10-13 |
 LEXIVA 78205433 2827902 Dead/Cancelled |
VIIV HEALTHCARE COMPANY 2003-01-21 |
 LEXIVA 75598528 not registered Dead/Abandoned |
SmithKline Beecham plc. 1998-12-03 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.